Manipal Health Enterprises has launched its IPO, with brokerage Anand Rathi recommending a long-term subscription despite a high valuation of 85.4x FY26 earnings. The company operates 49 hospitals with 13,037 beds, making it one of India's largest private healthcare providers. Investors should weigh the company's regional dominance against the premium pricing.
Detailed Coverage
Manipal Health Enterprises Limited has entered the primary market with its initial public offering (IPO), seeking to capitalize on its position as a major player in the Indian healthcare sector. Brokerage firm Anand Rathi has issued a 'Subscribe Long Term' recommendation for the issue, citing the company's extensive operational footprint across the country.
Valuation and Market Context
At the upper end of the price band, the IPO values Manipal Health at a price-to-earnings (P/E) multiple of 85.4x based on its fiscal year 2026 earnings. This valuation translates to a post-issue market capitalization of ₹7,76,056 million. For context, this valuation reflects a premium compared to some of its peers in the organized healthcare space, which often trade at varying multiples depending on their growth rate, bed capacity, and regional concentration. Investors may need to evaluate whether the company’s expansion plans and market share justify this valuation over the long term.
Operational Scale and Reach
As of March 31, 2026, the company managed a network of 49 hospitals with a total of 13,037 licensed beds. This makes it the largest private hospital chain in India in terms of authorized bed capacity and the second-largest by the number of facilities. Financial data for the fiscal year 2026 shows operational revenue of ₹103,357.51 million, with pro forma figures reaching ₹109,356.18 million.
The company’s strategy focuses on regional dominance. It currently holds the largest market share among private hospital chains in Karnataka. It also maintains a strong presence in the Maharashtra and Goa region, and across Eastern India, including states like West Bengal, Odisha, Jharkhand, and Sikkim. Specifically, its bed distribution is concentrated with 6,404 beds in Karnataka, 2,188 in Maharashtra and Goa, and 2,887 across the eastern states.
Investor Monitorables
While the company’s scale provides a business advantage in its core regions, investors should be mindful of the risks associated with high valuations and the capital-intensive nature of the hospital business. The healthcare sector is often impacted by regulatory changes regarding pricing and quality standards, as well as the need for continuous capital spending to upgrade medical equipment and maintain infrastructure. Success in the long term will depend on the company’s ability to manage its debt, improve operational efficiency across newly acquired or expanded facilities, and maintain consistent profit margins in a competitive market. Potential investors should track future quarterly results to monitor whether the company can sustain its revenue growth and translate its large bed capacity into higher profitability.